DMAAU Drugs Made In America Acquisition Corp. - Units
NASDAQ · N/A · View on SEC EDGAR ↗ close Oct 1, 2026 10-K/10-Q Aug 14, 2026DMAAU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DMAAU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Valuation (TTM)
| Metric | Trend | Q4 2026 |
|---|---|---|
| Net Income TTM | $8M |
Most recent period on the left · null values shown as ·
Institutional owners (13F) 4 filers · $3.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (0 vs prior Q) | 0 (-2 vs prior Q) | 2 (+2 vs prior Q) | 0 (-2 vs prior Q) | +9 |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| KRYGER CAPITAL Ltd | $3,042,657 | 303,810 | 83.62% | Shares |
| CLEAR STREET LLC | $473,894 | 45,920 | 13.02% | Shares |
| Clear Street Group Inc. | $106,153 | 10,005 | 2.92% | Shares |
| UBS Group AG | $16,180 | 1,525 | 0.44% | Shares |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.